Keros Therapeutics Inc (KROS) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Keros Therapeutics Inc   (NASDAQ: KROS)

Keros Therapeutics Inc

Officers & Directors


Keros Therapeutics Inc. Executives:

Jasbir Seehra, Ph.D.
Chief Executive Officer - (Principal Executive Officer)

Keith Regnante
Chief Financial Officer - (Principal Financial Officer and Principal Accounting Officer)

Keros Therapeutics Inc. Directors:

Carl Gordon
Director

Mary Ann Gray
Director

Ran Nussbaum
Director

Tomer Kariv
Director

Alpna Seth
Director

Jasbir Seehra
Chief Executive Officer and Director - (Principal Executive Officer)

Julius Knowles
Director

Nima Farzan
Director ,

Keros Therapeutics Inc currently has 78 employees.






KROS Management Effectiveness KROS Revenue per Employee KROS Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.